Rui Zhu

This inventor holds 1 USPTO granted patent. Top assignee: Adarx Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rui Zhu. Retrieved from https://idiyas.com/inventor/rui-zhu-a5v2zfxo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rui Zhu - Innovator in Complement Factor B Modulation

Introduction

Rui Zhu is a notable inventor recognized for his contributions to the field of biotechnology. He is currently associated with Adarx Pharmaceuticals, Inc., where he focuses on developing innovative solutions in medical science. With a keen interest in complement factor modulation, Rui has made significant strides in his research.

Latest Patents

Rui Zhu holds a patent titled "Complement Factor B-Modulating Compositions and Methods of Use Thereof." This patent highlights his innovative approach to modulating complement factors, which can have important implications in treating various diseases.

Career Highlights

Throughout his career, Rui has demonstrated a commitment to advancing scientific knowledge and improving healthcare outcomes. His work at Adarx Pharmaceuticals, Inc. has positioned him as a key player in the biotechnology sector. With 1 patent to his name, he continues to push the boundaries of what is possible in his field.

Collaborations

Rui collaborates with talented individuals, including his coworker Zhiqing (Joel) Zhou, to enhance the impact of their research. Together, they work towards innovative solutions that can benefit the medical community.

Conclusion

Rui Zhu's contributions to biotechnology, particularly in complement factor modulation, showcase his dedication to innovation and research. His work at Adarx Pharmaceuticals, Inc. and his patent reflect his significant role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…